| Filed On | Filing |
|---|---|
| 08 Aug 2025 |
8-K/A: Results of Operations and Financial Condition
Last patient visit completed in Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis; topline results expected in mid-September 2025. |
| 14 Apr 2022 | 8-K/A: Other Events |
Loading...
